Cyclodextrins and Oligonucleotide Delivery to Solid Tumours

References

• Abdou, S., Collomb, J., Sallas, F., Marsura, A. and Finance, C. (1997) “Beta-cyclodextrin derivatives as carriers to enhance the antiviral activity of an antisense oligonucleotide directed toward a coronavirus intergenic consensus sequence”, Arch. Virol. 142, 1585–1602.
   Web of Science ®Google Scholar
• Agarwal, S. (1999) “Factors affecting the specificity and mechanism of action of antisense oligonucleotide”, Antisense Nucl. Acid Drug Dev. 9, 371–375.
   Google Scholar
• Agu, U.R., Jorissen, M., Willems, T., van den Mooter, G., Kinget, R., Verbeke, N. and Augustijns, P. (2000) “Safety assessment of selected cyclodextrins—effect on ciliary activity using a human cell suspension culture model exhibiting in vitro ciliogenesis”, Int. J. Pharm. 193, 219–226.
   Google Scholar
• Alvarez-Salas, L.M., Arpawong, T.E. and DiPaolo, J.A. (1999) “Growth inhibition of cervical tumor cells by antisense oligodeoxynucleotides directed to the Human Papillomavirus Type 16 E6 gene”, Antisense Nucl. Acid Drug Dev. 9, 441–450.
   PubMedGoogle Scholar
• Beltinger, C., Saragovi, H.U., Smith, R.M., Lesauteur, L., Shah, N., Dedionisio, L., Christensen, L., Raible, A., Jarett, L. and Gerwirtz, A.M. (1995) “Binding, uptake, and intracellular trafficking of phosphorothioate-modified oligodeoxynucleotides”, J. Clin. Investig. 95, 1814–1823.
   Google Scholar
• Benimetskaya, L., Loike, J.D., Kahangir, K., Loike, G., Silverstein, S., Cao, L., Khoury, J.E., Cai, T. and Stein, C.A. (1997) “Mac-1 (CD11b/CD18) is an oligodeoxynucleotide binding protein”, Nat. Med. 3, 414–420.
   Web of Science ®Google Scholar
• Benimetskaya, L., Tonkinson, J. and Stein, C.A. (1999) “Determination of cellular internalization of fluoresceinated oligonucleotides”, Meth. Enzymol. 212, 287–297.
   Google Scholar
• Bergan, R., Hakim, F., Schwartz, G.N., Kyle, E., Cepada, R., Szabo, J.M., Fowler, D., Gress, R. and Neckers, L. (1996) “Electroporation of synthetic oligodeoxyribonucleotides: A novel technique for ex vivo bone marrow purging”, Blood 88, 731–741.
   PubMed Web of Science ®Google Scholar
• Bolyan, D. and Ganzler, K. (1998) “Chiral separation of antisense oligonucleotides: A feasibility study”, Biomed. Chromatogr. 12, 179–180.
   Google Scholar
• Budker, V., Zhang, G., Knechtle, S. and Wolff, J.A. (1996) “Naked DNA delivered intraportally expresses in hepatocytes”, Gene Ther. 3, 593–598.
   PubMed Web of Science ®Google Scholar
• Budker, V., Budker, T., Zhang, G., Subbotin, V., Loomis, A. and Wolff, J.A. (2000) “Hypothesis: A naked plasmid DNA is taken up by cells in vivo by a receptor-mediated process”, J. Gene Med. 2, 76–88.
   Google Scholar
• Cao, A., Briane, D., Coudert, R., Vassy, J., Lievre, J., Olsman, E., Tamboise, E., Salzmann, J.L., Rigaut, J.P. and Taillandier, E. (2000) “Delivery and pathway in MCF7 cells of DNA vectorized by cationic liposomes derived from cholesterol”, Antisense Nucl. Acid Drug Dev. 10, 369–380.
   PubMedGoogle Scholar
• Carpenter, T.O., Gerloczy, A. and Pitha, J. (1995) “Safety of parenteral hydroxylpropyl b-cyclodextrin”, J. Pharm. Sci. 84, 222–225.
   PubMed Web of Science ®Google Scholar
• Childs, G.V. (1999). Biology of the cell. Accessed on 23/03/00 from the internet at http://cellbio.utmb.edu/cellbio/nuclear_envelope.htm Croyle, M.A., Roessler, B.J., Hsu, C.-P., Sun, R. and Amidon, G.L. (1998) “Beta cyclodextrins enhance adenoviral-mediated gene delivery to the intestine”, Pharm. Res. 15, 1348–1355.
   Google Scholar
• Cserhati, T., Forgacs, E. and Szejtli, J. (1996) “Inclusion complex formation of antisense nucleotides with hydroxypropyl-b-cyclo- dextrin”, Int. J. Pharm. 141, 1–7.
   Google Scholar
• Dass, C.R. (2000) “Apolipoprotein A-I, phospholipid vesicles and cyclodextrins as potential anti-atherosclerotic drugs: Delivery, pharmacokinetics and efficacy”, Drug Delivery 7, 161–182.
   PubMed Web of Science ®Google Scholar
• Dass, C.R. (2002) “Biochemical and biophysical characteristics of lipoplexes pertinent to solid tumour gene therapy”, Int. J. Pharm. 241(1),1–25.
   Google Scholar
• Dass, C.R. and Burton, M.A. (1999) “Lipoplexes and tumours”, J. Pharmacy Pharmacol. 51, 755–770.
   PubMed Web of Science ®Google Scholar
• Dass, C.R. and Burton, M.A. (2002) “A model for evaluating selective delivery of plasmid DNA to tumours via the vasculature”, Cancer Biother. Radiopharm. 17(5),501–505.
   Google Scholar
• Dass, C.R. and Burton, M.A. (2003) “Modified microplex vector enhances transfection of cells in culture while maintaining tumour-selective gene delivery in-vivo”, J. Pharm. Pharmacol. 55(1),19–25. Dass, C.R. and Su, T. (2000) “Delivery of lipoplexes for genotherapy of solid tumours: Role of vascular endothelial cells”, J. Pharm. Pharmacol. 52, 1301–1317.
   Google Scholar
• Dass, C.R., Saravolac, E.G., Li, Y. and Sun, L.Q. (2002) “Cellular uptake, distribution, and stability of 10-23 deoxyribozymes”, Antisense Nucl. Acid Drug Dev. 12(5),289–299.
   PubMedGoogle Scholar
• Davidson, W.S., Rodrigueza, W.V., Lund-Katz, S., Johnson, W.J., Rothblat, G.H. and Phillips, M.C. (1995) “Effects of particle size on the efflux of cellular free cholesterol”, J. Biol. Chem. 270, 17106–17113.
   Web of Science ®Google Scholar
• Dowty, M.E., Williams, P., Zhang, G., Hagstrom, J.E. and Wolff, J.A. (1995) “Plasmid DNA entry into postmitotic muclei of primary rat myotubes”, Proc. Natl Acad. Sci. USA 92, 4572–4576.
   PubMed Web of Science ®Google Scholar
• Dworetzky, S.I. and Feldherr, C.M. (1988) “Translocation of RNA- coated gold particles through the nuclear pores of oocytes”, J. Cell Biol. 106, 575–584.
   PubMed Web of Science ®Google Scholar
• Epa, W.R., Greferath, U., Shafton, A., Rong, P., Delbridge, L.M., Bennie, A. and Barrett, G.L. (2000) “Downregulation of the p75 neurotrophin receptor in tissue culture and in vivo, using b-cyclodextrin-adamantane- oligonucleotide conjugates”, Antisense Nucl. Acid Drug Dev. 10, 469– 478.
   PubMedGoogle Scholar
• Ferezou, J., Riottot, M., Serougne, C., Cohen-Solal, C., Catala, I., Alquier, C., Parquet, M., Juste, C., Lafont, H., Mathe, D., Corring, T. and Lutton, C. (1997) “Hypocholesterolemic action of b-cyclodextrin and its effects on cholesterol metabolism in pigs fed a cholesterol- enriched diet”, J. Lipid Res. 38, 86–100.
   PubMed Web of Science ®Google Scholar
• Flourie, B., Molis, C. and Achour, L. (1993) “Fate of b-cyclodextrin in the human intestine”, J. Nutr. 123, 676–680.
   Web of Science ®Google Scholar
• Flynn, S.M., George, S.T., White, L., Devonish, W. and Takle, G.B. (1999) “Water-soluble, meso-substituted cationic porphyrins— a family of compounds for cellular delivery of oligonucleotides”, Biotechniques 26, 736–746.
   PubMed Web of Science ®Google Scholar
• Frijlink, H.W., Eissens, A.C., Hefting, N.R., Poelstra, K., Lerk, C.F. and Meijer, D.K.F. (1991) “The effect of parenterally administered cyclodextrins on cholesterol levels in the rat”, Pharm. Res. 8, 9-16. Geselowitz, D. and Neckers, L. (1992) “Analysis of oligonucleotide binding, internalization, and intracellular trafficking utilizing a novel radiolabeled crosslinker”, Antisense Res. Dev. 2, 17–25.
   PubMedGoogle Scholar
• Gonzalez, H., Hwang, S.J. and Davis, M.E. (1999) “New class of polymers for the delivery of macromolecular therapeutics”, Bioconjug. Chem. 10, 1068–1074.
   Google Scholar
• Go¨rlich, D. and Mattaj, I.W. (1996) “Nucleocytoplasmic transport”, Science 271, 1513–1518.
   PubMed Web of Science ®Google Scholar
• Habus, I., Zhao, Q. and Agarwal, S. (1995) “Hybridization properties, nuclease stability, and cellular uptake of the oligonucleotide-amino- b-cyclodextrins and adamantane conjugates”, Bioconjug. Chem. 6, 327–331.
   Google Scholar
• Irie, T. and Uekama, K. (1997) “Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation”, J. Pharm. Sci. 86, 147–162.
   PubMed Web of Science ®Google Scholar
• Irie, T., Fukunaga, K., Garwood, M.K., Carpenter, T.O., Pitha, J. and Pitha, J. (1992) “Hydroxypropylcyclodextrins in parenteral use. II. Effects on transport and disposition of lipids in rabbit and humans”, J. Pharm. Sci. 81, 524–528.
   PubMed Web of Science ®Google Scholar
• Iversen, P.L., Zhu, S., Meyer, A. and Zon, G. (1992) “Cellular uptake and subcellular distribution of phosphorothioate oligonucleotides into cultured cells”, Antisense Res. Dev. 2(3),211–222.
   Google Scholar
• Izaurralde, E. and Mattaj, I.W. (1995) “RNA export”, Cell 81, 153-159. Jain, R.K. (1996) “1995 Whitaker Lecture: Delivery of molecules, particles, and cells to solid tumors”, Ann. of Biomed. Eng. 24, 457–473.
   Google Scholar
• Jansen, B., Wadl, H., Inoue, S.A., Trulzsch, B., Selzer, E., Duchene, M., Eichler, H.G., Wolff, K. and Pehamberger, H. (1995) “Phosphorothioate oligonucleotides reduce melanoma growth in a SCID-hu mouse model by a nonantisense mechanism”, Antisense Res. Dev. 5, 271–277.
   Web of Science ®Google Scholar
• Kohn, S., Nagy, J.A., Dvorak, H.F. and Dvorak, A.M. (1992) “Pathways of macromolecular tracer transport across venules and small veins. Structural basis for the hyperpermeability of tumor blood vessels”, Lab Investig. 67, 596–607.
   PubMed Web of Science ®Google Scholar
• Kong, G., Braun, R.D. and Dewhirst, M.W. (2000) “Hyperthermia enables tumor-specific nanoparticle delivery: Effect of particle size”, Cancer Res. 60, 4440–4445.
   PubMed Web of Science ®Google Scholar
• Laktionov, P.P., Dazard, J-E., Vives, E., Rykove, E.Y., Piette, J., Vlassov, V.V. and Lebleu, B. (1999) “Characterisation of membrane oligonucleotide-binding proteins and oligonucleotide uptake in keratinocytes”, Nucl. Acids Res. 27, 2315–2324.
   PubMed Web of Science ®Google Scholar
• Lappalainen, K., Urtti, A., Ja¨a¨skela¨inen, I., Syrja¨anen, K. and Syrja¨nen, S. (1994) “Cationic liposomes mediated delivery of antisense oligonucleotides targeted to HPV E7 mRNA in CaSki cells”, Antiviral Res. 23, 119–130.
   PubMed Web of Science ®Google Scholar
• Leonetti, J.P., Mechti, N., Degols, G., Gagnor, C. and Lebleu, B. (1991) “Intracellular distribution of microinjected antisense oligo- nucleotides”, Proc. Natl Acad. Sci. USA 88, 2701–2706.
   Google Scholar
• Liu, S.M., Cogny, A., Kockx, M., Dean, R.T., Gaus, K., Jessup, W. and Kritharides, L. (2003 Jun) “Cyclodextrins differentially mobilize free and esterified cholesterol from primary human foam cell macro- phages”, J. Lipid Res. 44(6),1156–1166.
   Google Scholar
• Matsukura, M., Shinozuka, K., Zon, G., Mitsuya, H., Reitz, M., Cohen, J.S. and Broder, S. (1987) “Phosphorothioate analogs of oligodeoxy- nucleotides: inhibitors of replication and cytopathic effects of human immunodeficiency virus”, Proc. Natl Acad. Sci. USA 84, 7706–7710.
   PubMed Web of Science ®Google Scholar
• Melchior, F. and Gerace, L. (1995) “Mechanisms of nuclear protein import”, Curr. Opin. Cell Biol. 7, 310–318.
   PubMed Web of Science ®Google Scholar
• Mellman, I. (1996) “Endocytosis and molecular sorting”, Annu. Rev. Cell Dev. Biol. 12, 575–625.
   PubMed Web of Science ®Google Scholar
• Noonberg, S.B., Garavoy, M.R. and Hunt, C.A. (1993) “Characteristics of oligonucleotide uptake in human keratinocyte cultures”, J. Investig. Dermatol. 101, 727–731.
   PubMed Web of Science ®Google Scholar
• Pichon, C., Freulon, I., Midoux, P., Mayer, R., Monsigny, M. and Roche, A.C. (1997) “Cytosolic and nuclear delivery of oligonucleotides mediated by an amphiphilic anionic peptide”, Antisense Res. Dev. 7, 335–343.
   Web of Science ®Google Scholar
• Pin˜ol-Roma, S. and Dreyfuss, G. (1992) “Shuttling of pre-mRNA binding proteins between nucleus and cytoplasm”, Nature 355, 730–732.
   PubMed Web of Science ®Google Scholar
• Pouton, C.W. (1998) “Nuclear import of polypeptides, polynucleotides and supramolecular complexes”, Adv. Drug Deliv. Rev. 34, 51–64.
   PubMed Web of Science ®Google Scholar
• Regnier, V., Tahiri, A., Andre, N., Lemaitre, M., Le Doan, T. and Preat, V. (2000) “Electroporation-mediated delivery of 30 -protected phospho- diester oligodeoxynucleotides to the skin”, J. Contr. Rel. 67, 337–346.
   PubMed Web of Science ®Google Scholar
• Riottot, M., Olivier, P., Huet, A., Caboche, J.-J., Parquet, M., Khallou, J. and Lutton, C. (1993) “Hypolipidemic effects of b-cyclodextrin in the hamster and in the genetically hypercholesterolemic Rico rat”, Lipids 28, 181–188.
   PubMed Web of Science ®Google Scholar
• Saison-Behmoaras, T., Tocque, B., Rey, I., Chassignol, M., Thuong, N.T. and Helene, C. (1991) “Short modified antisense oligonucleotides directed against Ha-ras point mutation induce selective cleavage of the mRNA and inhibit T24 cell proliferation”, EMBO J. 10, 1111–1118.
   PubMed Web of Science ®Google Scholar
• Santiago, F.S., Lowe, H.C., Kavurma, M.M., Chesterman, C.N., Baker, A., Atkins, D.G. and Khachigian, L.M. (1999) “New DNA enzyme targeting Egr-1 mRNA inhibits vascular smooth muscle proliferation and regrowth after injury”, Nat. Med. 5, 1264–1269.
   Web of Science ®Google Scholar
• Sharkey, E.M., O’Neill, H.B., Kavarana, M.J., Wang, H., Creighton, D.J., Sentz, D.L. and Eiseman, J.L. (2000) “Pharmacokinetics and antitumor properties in tumor-bearing mice of an enediol analogue inhibitor of glyoxalase I”, Cancer Chemother. Pharmacol. 46, 156–166.
   Web of Science ®Google Scholar
• Sinisterra, R.D., Shastri, V.P., Najjar, R. and Langer, R. (1999) “Encapsulation and release of rhodium (II) citrate and its association complex with hydroxypropyl-b-cyclodextrin from biodegradable polymer microspheres”, J. Pharm. Sci. 88, 574–576.
   PubMed Web of Science ®Google Scholar
• Spiller, D.G. and Tidd, D.M. (1995) “Nuclear delivery of antisense oligodeoxyribonucleotides through reversible permeabilization of human leukemia cells with streptolysin-O”, Antisense Res. Dev. 5, 13–21.
   Web of Science ®Google Scholar
• Stein, C.A., Tonkinson, J.L., Zhang, L.M., Yakubov, L., Gervasoni, J., Taub, R. and Rotenberg, S. (1993) “Dynamics of the internalization of phosphodiester oligodexoynucleotides in HL60 cells”, Biochem- istry 32, 4855–4862.
   PubMed Web of Science ®Google Scholar
• Stoffler, D., Fahrenkrog, B. and Aebi, U. (1999) “The nuclear pore complex: From molecular architecture to functional dynamics”, Curr. Opin. Cell Biol. 11, 391–401.
   PubMed Web of Science ®Google Scholar
• Sun, D. and Gilboe, D.D. (1994) “Effect of the platelet-activating factor antagonist BN50739 and its diluents on mitochondrial respiration and membrane lipids during and following cerebral ischemia”, J. Neurochem. 62, 1929–1938.
   PubMed Web of Science ®Google Scholar
• Sun, L-Q., Cairns, M.J., Saravolac, E.G., Baker, A. and Gerlach, W.L. (2000) “Catalytic nucleic acids: From lab to applications”, Pharmacol. Rev. 52, 325–347.
   Google Scholar
• Toyoda, K., Shada, T., Uneyama, C., Takada, K. and Takahashi, M. (1997) “Carcinogenicity study of beta-cyclodextrin in F344 rats”, Food Chem. Toxicol. 35, 331–336.
   Web of Science ®Google Scholar
• Walker, T.L., Dass, C.R., DeCruz, E.E. and Burton, M.A. (1998) “A method for intratumoral continuous infusion of antisense oligodeoxynucleotides”, J. Pharm. Sci. 87, 387–389.
   PubMed Web of Science ®Google Scholar
• Walker, T.L., Dass, C.R. and Burton, M.A. (2002) “Enhanced in vivo tumour response from combination carboplatin and low dose c-myc antisense oligonucleotides”, Anticancer Res. 14, 2237–2245.
   Google Scholar
• White, P.J., Fogarty, R.D., Liepe, I.J., Delany, P.M., Werther, G.A. and Wraight, C.J. (1999) “Live confocal microscopy of oligonucleotide uptake by keratinocytes in human skin grafts on nude mice”, J. Investig. Dermatol. 112, 887–892.
   PubMed Web of Science ®Google Scholar
• Wu, N.Z., Da, D., Rudoll, T.L., Needham, D., Whorton, A.R. and Dewhirst, M.W. (1993) “Increased microvascular permeability contributes to preferential accumulation of Stealth liposomes in tumor tissue”, Cancer Res. 53, 3756–3770.
   Google Scholar
• Yakubov, L.A., Deeva, E.A., Zaryotova, V.F., Ivanova, E.M., Ryte, A.S., Yurchenko, L.V. and Vlassov, V.V. (1989) “Mechanisms of oligonucleotide uptake by cells: Involvement of specific receptors?”, Proc. Natl Acad. Sci. USA 86, 6454–6458.
   PubMed Web of Science ®Google Scholar
• Zamecnik, P., Aghajanian, J., Zamecnik, M., Goodchild, J. and Witman, G. (1994) “Electron micrographic studies of transport of oligodeoxy- nucleotides across eukaryotic cell membranes”, Proc. Natl Acad. Sci. USA 91, 3156–3160.
   PubMed Web of Science ®Google Scholar
• Zelphati, O. and Szoka, F.C., Jr. (1996) “Intracellular distribution and mechanism of delivery of oligonucleotides mediated by cationic lipids”, Pharmacol. Res. 13, 1367–1372.
   Google Scholar
• Zhao, Q., Matson, S., Herrera, C.J., Fisher, E., Yu, H. and Krieg, A.M. (1993) “Comparison of cellular binding and uptake of antisense phosphodiester, phosphorothioate, and mixed phosphorothioate and methylphosphonate oligonucleotides”, Antisense Res. Dev. 3, 53-66. Zhao, Q., Temsamani, J. and Agarwal, S. (1995) “Use of cyclodextrin and its derivatives as carriers for oligonucleotide delivery”, Antisense Res. Dev. 5, 185–192.
   Google Scholar
• Zhao, Q., Temsamani, J., Tadarola, P.L., Jiang, Z. and Agarwal, S. (1996) “Effect of different chemically modified oligodeoxynucleotides on immune stimulation”, Biochem. Pharmacol. 51, 173–182.
   Web of Science ®Google Scholar